[1]
|
赵华平, 伍传琦. 血清肿瘤标志物联合检测在肺癌诊断中的价值[J]. 中外医学研究, 2011, 33(22): 355-356.
|
[2]
|
Pio, R., Gar-cia, J., Corrales, L., et al. (2010) Complement Factor H Is Elevated in Bronchoalveolar Lavage Fluid and Sputum from Patients with Lung Cancer. Cancer Epidemiology, Biomarkers & Prevention, 19, 2665-2672.
https://doi.org/10.1158/1055-9965.EPI-10-0467
|
[3]
|
Liu, D., Peng, H., Sun, Q., Zhao, Z., Yu, X., Ge, S. and Wang, Y. (2017) The Indirect Efficacy Comparison of DNA Methylation in Sputum for Early Screening and Auxiliary Detection of Lung Cancer: A Meta-Analysis. International Journal of Environmental Research and Public Health, 14, 679. https://doi.org/10.3390/ijerph14070679
|
[4]
|
祁松楠, 钱忠萍, 顾国浩, 等. 肺癌血清自身抗体及其应用的研究进展[J]. 国际检验医学杂志, 2014(18) 2506-2509.
|
[5]
|
Pereirafaca, S.R., Kuick, R., Puravs, E., Zhang, Q., Krasnoselsky, A.L., Phanstiel, D., et al. (2007) Identification of 14-3-3𝛉 as an Antigen That Induces a Humoral Response in Lung Cancer. Cancer Research, 67, 12000.
https://doi.org/10.1158/0008-5472.CAN-07-2913
|
[6]
|
袁绮. p53等七种肿瘤相关抗体在肺癌早期诊断中的意义[D]: [硕士学位论文]. 大连: 大连医科大学, 2017.
|
[7]
|
Phillips, M., Cataneo, R.N., Cummin, A.R., Gagliardi, A.J., Gleeson, K., Greenberg, J., et al. (2003) Detection of Lung Cancer with Volatile Markers in the Breath. Chest, 123, 2115-2123. https://doi.org/10.1378/chest.123.6.2115
|
[8]
|
Poli, D., Carbognani, P., Corradi, M., Goldoni, M., Acampa, O., Balbi, B., et al. (2005) Exhaled Volatile Organic Compounds in Patients with Non-Small Cell Lung Cancer: Cross Sectional and Nested Short-Term Follow-Up Study. Respiratory Research, 6, 71. https://doi.org/10.1186/1465-9921-6-71
|
[9]
|
Schumer, E.M., Trivedi, J.R., Berkel, V.V., Black, M.C., Li, M., Fu, X.A., et al. (2015) High Sensitivity for Lung Cancer Detection Using Analysis of Exhaled Carbonyl Compounds. Journal of Thoracic & Cardiovascular Surgery, 150, 1517-1524. https://doi.org/10.1016/j.jtcvs.2015.08.092
|
[10]
|
Carpagnano, G.E., Foschino-Barbaro, M.P., Mulé, G., Resta, O., Tommasi, S., Mangia, A., et al. (2005) 3p Microsatellite Alterations in Exhaled Breath Condensate from Patients with Nonecsmall Cell Lung Cancer. American Journal of Respiratory & Critical Care Medicine, 172, 738. https://doi.org/10.1164/rccm.200503-439OC
|
[11]
|
沈巨信, 秦娥, 周国忠, 等. 呼出气冷凝液癌胚抗原检测在非小细胞肺癌诊断和分期中的意义[J]. 中国卫生检验杂志, 2017(12): 1719-1720.
|
[12]
|
Chen, X., Wang, X., He, H., Liu, Z., Hu, J.F. and Li, W. (2015) Combination of Circulating Tumor Cells with Serum Carcinoembryonic Antigen Enhances Clinical Prediction of Non-Small Cell Lung Cancer. Plos One, 10, e0126276.
https://doi.org/10.1371/journal.pone.0126276
|
[13]
|
Bettegowda, C., Sausen, M., Leary, R.J., Kinde, I., Wang, Y., Agrawal, N., et al. (2014) Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies. Science Translational Medicine, 6, 224ra24.
https://doi.org/10.1126/scitranslmed.3007094
|
[14]
|
Roth, C., Kasimirbauer, S., Pantel, K. and Schwarzenbach, H. (2011) Screening for Circulating Nucleic Acids and Caspase Activity in the Peripheral Blood as Potential Diagnostic Tools in Lung Cancer. Molecular Oncology, 5, 281-291. https://doi.org/10.1016/j.molonc.2011.02.002
|
[15]
|
Zhou, X., Wen, W., Shan, X., et al. (2107) A Six-MicroRNA Panel in Plasma Was Identified as a Potential Biomarker for Lung Adenocarcinoma Diagnosis. Oncotarget, 8, 6513-6525.
|
[16]
|
Cazzoli, R., Buttitta, F., Di, N.M., Malatesta, S., Marchetti, A., Rom, W.N., et al. (2013) Micrornas Derived from Circulating Exosomes as Noninvasive Biomarkers for Screening and Diagnosing Lung Cancer. Journal of Thoracic Oncology, 8, 1156-1162. https://doi.org/10.1097/JTO.0b013e318299ac32
|
[17]
|
Taverna, S., Giallombardo, M., Gilbazo, I., Carreca, A.P., Castiglia, M., Chacártegui, J., et al. (2016) Exosomes Isolation and Characterization in Serum Is Feasible in Non-Small Cell Lung Cancer Patients: Critical Analysis of Evidence and Potential Role in Clinical Practice. Oncotarget, 7, 28748-28760. https://doi.org/10.18632/oncotarget.7638
|
[18]
|
Zhang, X., Li, W., Hou, Y., Niu, Z., Zhong, Y., Zhang, Y., et al. (2014) Compar-ative Membrane Proteomic Analysis between Lung Adenocarcinoma and Normal Tissue by Itraq Labeling Mass Spectrometry. American Journal of Translational Research, 6, 267-280.
|
[19]
|
Yu, L., Shen, J., Mannoor, K., Guarnera, M. and Jiang, F. (2014) Identification of ENO1 as a Potential Sputum Biomarker for Early Stage Lung Cancer by Shotgun Proteomics. Clinical Lung Cancer, 15, 372-378.e1.
https://doi.org/10.1016/j.cllc.2014.05.003
|
[20]
|
Jin, H., Xiao, C., Pei, Y., Fu, J., Zhi, L., Peng, H., et al. (2015) Identification and Verification of Transgelin-2 as a Potential Biomarker of Tumor-Derived Lung-Cancer Endothelial Cells by Comparative Proteomics. Journal of Proteomics, 136, 77-88. https://doi.org/10.1016/j.jprot.2015.12.012
|
[21]
|
Lópezsánchez, L.M., Juradogámez, B., Feucollado, N., Valverde, A., Cañas, A., Fernándezrueda, J.L., et al. (2017) Exhaled Breath Condensate Biomarkers for the Early Diagnosis of Lung Cancer Using Proteomics. American Journal of Physiology Lung Cellular & Molecular Physiology, 313, L664-L676.
|